Ocular Drug Delivery Nanowafer with Enhanced Therapeutic Efficacy

imagine source: ACSNano.org

imagine source: ACSNano.org

If you want to take a peak into the future, check out the publication recently made available in an open access article from the American Chemical Society titled: “Ocular Drug Delivery Nanowafer with Enhanced Therapeutic Efficacy” by Yuan et al that provides an intriguing analysis of what topical drug therapy may look like in the not so distant future. While we typically consider topical ophthalmic drop delivery is direct and simple, the authors point out the challenging and unique barriers associated with the ocular surface that impede “adequate drug delivery and therapeutic efficacy”. They point out barriers such as reflex tearing, constant blinking, tight cellular junctions and nasolacrimal drainage that results in decreased contact time to a few minutes. The development of the nano wafer for ocular drug delivery is described as a tiny transparent disc that can be applied to the ocular surface and withstand constant blinking and contain various drugs that could be released over a few hours to days. After the wafer completes the drug delivery, it simply dissolves and fades away.

The initial step was to determine the ability of polymers to elicit pro-inflammatory and pro-angiogenic responses in a mouse model and later, demonstrate the ability of the nano wafers to release a drug (doxycycline) over time and due to its fluorescence, allowed monitoring pre corneal residence time and diffusion into the cornea by real-time imaging. One can only imagine the potential benefits for ocular therapeutics this may lead to from dry eye disease (DED), allergies, infections as well as intraocular therapies.

Read the full article here. (PDF)

Authors: XIaoyong Yuan et al.

Long-term Use of Autologous Serum 50% Eye Drops for the Treatment of Dry Eye Disease

Doctor Helps The Patient

As we continue through a rough winter and cold temperatures in most of the US, we must remember how our dry eye disease (DED) patients must be struggling. With their heaters tucked below the desk and the fire places roaring, low humidity is an evil … [Continue reading]

Oral Azithromycin Versus Doxycycline in Meibomian Gland Dysfunction: A Randomized Double-masked Open-label Clinical Trial

azromythcin versus doxycycline

Compliance is a critical factor in any treatment prescribed for our patients. Wouldn’t it be great if we could reduce the frequency of oral doses in patients having meibomian gland dysfunction (MGD) requiring same. A new study out in the Feb 2015 … [Continue reading]

Increased Tear Fluid Production as a Compensatory Response to Meibomian Gland Loss

reflex tears meibomian gland dysfunction

Compensatory mechanisms are common in our body's design. In fact recent evidence confirms compensatory tearing is how most dry eye disease (DED) patients can temporarily lower their tear osmolarity (TO) in a daily cyclical process in response to an … [Continue reading]

Dry Eye Disease After Refractive Surgery: Comparative Outcomes of Small Incision Lenticule Extraction VS LASIK

Eye Operation

One of the newest techniques in refractive surgery is the Small Incision Lenticule Extraction (SMILE) which utilizes a femtosecond laser to create an instra-stromal lenticule that is then removed through a small corneal incision. Significant dry eye … [Continue reading]

Correlation Between Tear Film Osmolarity, Dry Eye Disease and Rheumatoid Arthritis

skeletal hands - arthritis

With the recent advent of lab testing in eye care Sjogrens Syndrome (SS) has received much needed attention; but we must not forget about our patients having other autoimmune diseases that may well suffer from dry eye disease with no previous … [Continue reading]

Open Your Eyes to Osmolarity Testing!

open your eyes5.fw

In the latest edition of our In My Practice series, Dr. Alan Panzer discusses the numerous benefits of utilizing tear osmolarity in clinical practice. Dr. Panzer describes helpful strategies for determining which patients to test as well as how to … [Continue reading]

Detection of Early Markers for Sjögren Syndrome in Dry Eye Patients

rheumatologist dry eye sjogrens

Estimates are approximately 4 million Americans suffer from Sjögren’s Syndrome (SS) or about 1 in 10 of your dry eye patients. The hallmark symptoms are dry eye and dry mouth but Sjögren’s may also cause dysfunction of other organs such as the … [Continue reading]

Changing Dry Eye Disease in Your Practice: An Administrator’s Perspective


While it can be challenging to incorporate new instruments into a busy practice, the latest supplement in Ophthalmic Professional is proof that with a little dedication, team work and communication, administrators and office managers can achieve … [Continue reading]

Change in Tear Film Characteristics in Visual Display Terminal Users

Broker working on laptop visual terminal

More and more peer review evidence is confirming that video display terminal (VDT) users are more inclined to have dry eye disease (DED). In the recent Epub ahead of print from the EJO, Yazici et al. present additional evidence in their work titled … [Continue reading]